Project
SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Navigation
Downloads
Results for E2F6
Z-value: 2.39
Motif logo
Transcription factors associated with E2F6
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
E2F6
|
ENSG00000169016.12 | E2F transcription factor 6 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| E2F6 | hg19_v2_chr2_-_11606275_11606289 | -0.89 | 1.7e-07 | Click! |
Activity profile of E2F6 motif
Sorted Z-values of E2F6 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr8_+_95653427 | 12.39 |
ENST00000454170.2
|
ESRP1
|
epithelial splicing regulatory protein 1 |
| chr9_-_21994344 | 11.67 |
ENST00000530628.2
ENST00000361570.3 |
CDKN2A
|
cyclin-dependent kinase inhibitor 2A |
| chr8_+_95653373 | 11.33 |
ENST00000358397.5
|
ESRP1
|
epithelial splicing regulatory protein 1 |
| chr8_+_95653302 | 10.04 |
ENST00000423620.2
ENST00000433389.2 |
ESRP1
|
epithelial splicing regulatory protein 1 |
| chr2_-_166651152 | 7.95 |
ENST00000431484.1
ENST00000412248.1 |
GALNT3
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3) |
| chr5_-_141257954 | 7.77 |
ENST00000456271.1
ENST00000394536.3 ENST00000503492.1 ENST00000287008.3 |
PCDH1
|
protocadherin 1 |
| chr9_-_21994597 | 7.56 |
ENST00000579755.1
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A |
| chr1_-_159915386 | 7.23 |
ENST00000361509.3
ENST00000368094.1 |
IGSF9
|
immunoglobulin superfamily, member 9 |
| chr1_-_6321035 | 7.21 |
ENST00000377893.2
|
GPR153
|
G protein-coupled receptor 153 |
| chr19_+_39687596 | 7.02 |
ENST00000339852.4
|
NCCRP1
|
non-specific cytotoxic cell receptor protein 1 homolog (zebrafish) |
| chr14_+_23305760 | 6.36 |
ENST00000311852.6
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted) |
| chr12_+_4382917 | 6.15 |
ENST00000261254.3
|
CCND2
|
cyclin D2 |
| chr1_-_207206092 | 5.98 |
ENST00000359470.5
ENST00000461135.2 |
C1orf116
|
chromosome 1 open reading frame 116 |
| chr12_-_28123206 | 5.87 |
ENST00000542963.1
ENST00000535992.1 |
PTHLH
|
parathyroid hormone-like hormone |
| chr19_-_42947121 | 5.86 |
ENST00000601181.1
|
CXCL17
|
chemokine (C-X-C motif) ligand 17 |
| chr3_-_13921594 | 5.83 |
ENST00000285018.4
|
WNT7A
|
wingless-type MMTV integration site family, member 7A |
| chr10_-_105845674 | 5.54 |
ENST00000353479.5
ENST00000369733.3 |
COL17A1
|
collagen, type XVII, alpha 1 |
| chr12_+_69633407 | 5.53 |
ENST00000551516.1
|
CPSF6
|
cleavage and polyadenylation specific factor 6, 68kDa |
| chr14_+_24867992 | 5.23 |
ENST00000382554.3
|
NYNRIN
|
NYN domain and retroviral integrase containing |
| chr20_+_44098346 | 5.06 |
ENST00000372676.3
|
WFDC2
|
WAP four-disulfide core domain 2 |
| chr20_+_44098385 | 5.01 |
ENST00000217425.5
ENST00000339946.3 |
WFDC2
|
WAP four-disulfide core domain 2 |
| chr7_-_121036337 | 4.84 |
ENST00000426156.1
ENST00000359943.3 ENST00000412653.1 |
FAM3C
|
family with sequence similarity 3, member C |
| chr18_+_29078131 | 4.83 |
ENST00000585206.1
|
DSG2
|
desmoglein 2 |
| chr3_-_185542817 | 4.80 |
ENST00000382199.2
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
| chr1_-_113498616 | 4.73 |
ENST00000433570.4
ENST00000538576.1 ENST00000458229.1 |
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1 |
| chr19_-_11689752 | 4.69 |
ENST00000592659.1
ENST00000592828.1 ENST00000218758.5 ENST00000412435.2 |
ACP5
|
acid phosphatase 5, tartrate resistant |
| chr11_+_117947782 | 4.69 |
ENST00000522307.1
ENST00000523251.1 ENST00000437212.3 ENST00000522824.1 ENST00000522151.1 |
TMPRSS4
|
transmembrane protease, serine 4 |
| chr6_-_10413112 | 4.69 |
ENST00000465858.1
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
| chr10_-_105845536 | 4.66 |
ENST00000393211.3
|
COL17A1
|
collagen, type XVII, alpha 1 |
| chr5_+_3596168 | 4.65 |
ENST00000302006.3
|
IRX1
|
iroquois homeobox 1 |
| chr17_+_7344057 | 4.65 |
ENST00000575398.1
ENST00000575082.1 |
FGF11
|
fibroblast growth factor 11 |
| chr17_-_74582191 | 4.64 |
ENST00000225276.5
|
ST6GALNAC2
|
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 |
| chr22_-_37640277 | 4.60 |
ENST00000401529.3
ENST00000249071.6 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
| chr3_+_50192833 | 4.58 |
ENST00000426511.1
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
| chr1_+_201252580 | 4.50 |
ENST00000367324.3
ENST00000263946.3 |
PKP1
|
plakophilin 1 (ectodermal dysplasia/skin fragility syndrome) |
| chr12_-_50677255 | 4.45 |
ENST00000551691.1
ENST00000394943.3 ENST00000341247.4 |
LIMA1
|
LIM domain and actin binding 1 |
| chr11_+_46402583 | 4.42 |
ENST00000359803.3
|
MDK
|
midkine (neurite growth-promoting factor 2) |
| chr11_-_125366089 | 4.39 |
ENST00000366139.3
ENST00000278919.3 |
FEZ1
|
fasciculation and elongation protein zeta 1 (zygin I) |
| chr5_-_139726181 | 4.36 |
ENST00000507104.1
ENST00000230990.6 |
HBEGF
|
heparin-binding EGF-like growth factor |
| chr17_+_4901199 | 4.33 |
ENST00000320785.5
ENST00000574165.1 |
KIF1C
|
kinesin family member 1C |
| chr19_-_48673465 | 4.30 |
ENST00000598938.1
|
LIG1
|
ligase I, DNA, ATP-dependent |
| chrX_-_48326764 | 4.26 |
ENST00000413668.1
ENST00000441948.1 |
SLC38A5
|
solute carrier family 38, member 5 |
| chr19_+_3136115 | 4.21 |
ENST00000262958.3
|
GNA15
|
guanine nucleotide binding protein (G protein), alpha 15 (Gq class) |
| chr22_-_37640456 | 4.19 |
ENST00000405484.1
ENST00000441619.1 ENST00000406508.1 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
| chr15_+_41136216 | 4.07 |
ENST00000562057.1
ENST00000344051.4 |
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr6_+_150464155 | 4.06 |
ENST00000361131.4
|
PPP1R14C
|
protein phosphatase 1, regulatory (inhibitor) subunit 14C |
| chr19_-_53466095 | 3.97 |
ENST00000391786.2
ENST00000434371.2 ENST00000357666.4 ENST00000438970.2 ENST00000270457.4 ENST00000535506.1 ENST00000444460.2 ENST00000457013.2 |
ZNF816
|
zinc finger protein 816 |
| chr6_-_112194484 | 3.95 |
ENST00000518295.1
ENST00000484067.2 ENST00000229470.5 ENST00000356013.2 ENST00000368678.4 ENST00000523238.1 ENST00000354650.3 |
FYN
|
FYN oncogene related to SRC, FGR, YES |
| chr8_-_125740514 | 3.93 |
ENST00000325064.5
ENST00000518547.1 |
MTSS1
|
metastasis suppressor 1 |
| chr14_+_85996507 | 3.89 |
ENST00000554746.1
|
FLRT2
|
fibronectin leucine rich transmembrane protein 2 |
| chr2_-_166651191 | 3.87 |
ENST00000392701.3
|
GALNT3
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3) |
| chr2_-_70780770 | 3.82 |
ENST00000444975.1
ENST00000445399.1 ENST00000418333.2 |
TGFA
|
transforming growth factor, alpha |
| chr6_+_33168189 | 3.78 |
ENST00000444757.1
|
SLC39A7
|
solute carrier family 39 (zinc transporter), member 7 |
| chr15_+_101420028 | 3.78 |
ENST00000557963.1
ENST00000346623.6 |
ALDH1A3
|
aldehyde dehydrogenase 1 family, member A3 |
| chr19_+_10713112 | 3.77 |
ENST00000590382.1
ENST00000407327.4 |
SLC44A2
|
solute carrier family 44 (choline transporter), member 2 |
| chr1_-_85358850 | 3.75 |
ENST00000370611.3
|
LPAR3
|
lysophosphatidic acid receptor 3 |
| chr18_+_47088401 | 3.72 |
ENST00000261292.4
ENST00000427224.2 ENST00000580036.1 |
LIPG
|
lipase, endothelial |
| chr1_+_209602609 | 3.68 |
ENST00000458250.1
|
MIR205HG
|
MIR205 host gene (non-protein coding) |
| chr1_+_150480551 | 3.67 |
ENST00000369049.4
ENST00000369047.4 |
ECM1
|
extracellular matrix protein 1 |
| chr19_+_35606692 | 3.66 |
ENST00000406242.3
ENST00000454903.2 |
FXYD3
|
FXYD domain containing ion transport regulator 3 |
| chr1_-_27480973 | 3.66 |
ENST00000545949.1
ENST00000374086.3 |
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 |
| chrX_-_48326683 | 3.66 |
ENST00000440085.1
|
SLC38A5
|
solute carrier family 38, member 5 |
| chr14_-_36989427 | 3.64 |
ENST00000354822.5
|
NKX2-1
|
NK2 homeobox 1 |
| chr4_-_119274121 | 3.60 |
ENST00000296498.3
|
PRSS12
|
protease, serine, 12 (neurotrypsin, motopsin) |
| chr14_+_85996471 | 3.58 |
ENST00000330753.4
|
FLRT2
|
fibronectin leucine rich transmembrane protein 2 |
| chr12_-_6715808 | 3.56 |
ENST00000545584.1
|
CHD4
|
chromodomain helicase DNA binding protein 4 |
| chr8_-_125740730 | 3.52 |
ENST00000354184.4
|
MTSS1
|
metastasis suppressor 1 |
| chr3_+_50192457 | 3.49 |
ENST00000414301.1
ENST00000450338.1 |
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
| chr7_+_20370300 | 3.47 |
ENST00000537992.1
|
ITGB8
|
integrin, beta 8 |
| chr8_+_102504979 | 3.46 |
ENST00000395927.1
|
GRHL2
|
grainyhead-like 2 (Drosophila) |
| chr12_+_48499883 | 3.46 |
ENST00000546755.1
ENST00000549366.1 ENST00000552792.1 |
PFKM
|
phosphofructokinase, muscle |
| chr9_-_122131696 | 3.44 |
ENST00000373964.2
ENST00000265922.3 |
BRINP1
|
bone morphogenetic protein/retinoic acid inducible neural-specific 1 |
| chr18_+_29077990 | 3.43 |
ENST00000261590.8
|
DSG2
|
desmoglein 2 |
| chr9_-_136857403 | 3.42 |
ENST00000406606.3
ENST00000371850.3 |
VAV2
|
vav 2 guanine nucleotide exchange factor |
| chr2_-_230787879 | 3.42 |
ENST00000435716.1
|
TRIP12
|
thyroid hormone receptor interactor 12 |
| chr6_-_10412600 | 3.39 |
ENST00000379608.3
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
| chr1_+_150480576 | 3.38 |
ENST00000346569.6
|
ECM1
|
extracellular matrix protein 1 |
| chr11_-_119187826 | 3.36 |
ENST00000264036.4
|
MCAM
|
melanoma cell adhesion molecule |
| chr5_+_61602236 | 3.35 |
ENST00000514082.1
ENST00000407818.3 |
KIF2A
|
kinesin heavy chain member 2A |
| chr10_+_103912137 | 3.33 |
ENST00000603742.1
ENST00000488254.2 ENST00000461421.1 ENST00000476468.1 ENST00000370007.5 |
NOLC1
|
nucleolar and coiled-body phosphoprotein 1 |
| chr3_+_37903432 | 3.32 |
ENST00000443503.2
|
CTDSPL
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like |
| chr4_-_102268484 | 3.32 |
ENST00000394853.4
|
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme |
| chr2_-_70781087 | 3.32 |
ENST00000394241.3
ENST00000295400.6 |
TGFA
|
transforming growth factor, alpha |
| chr8_-_139926236 | 3.30 |
ENST00000303045.6
ENST00000435777.1 |
COL22A1
|
collagen, type XXII, alpha 1 |
| chr10_-_97050777 | 3.25 |
ENST00000329399.6
|
PDLIM1
|
PDZ and LIM domain 1 |
| chr16_-_65155833 | 3.23 |
ENST00000566827.1
ENST00000394156.3 ENST00000562998.1 |
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast) |
| chr3_-_151034734 | 3.22 |
ENST00000260843.4
|
GPR87
|
G protein-coupled receptor 87 |
| chr14_+_94640633 | 3.21 |
ENST00000304338.3
|
PPP4R4
|
protein phosphatase 4, regulatory subunit 4 |
| chr11_+_129939779 | 3.20 |
ENST00000533195.1
ENST00000533713.1 ENST00000528499.1 ENST00000539648.1 ENST00000263574.5 |
APLP2
|
amyloid beta (A4) precursor-like protein 2 |
| chr11_+_129939811 | 3.20 |
ENST00000345598.5
ENST00000338167.5 |
APLP2
|
amyloid beta (A4) precursor-like protein 2 |
| chr8_-_103424986 | 3.19 |
ENST00000521922.1
|
UBR5
|
ubiquitin protein ligase E3 component n-recognin 5 |
| chr7_-_143991230 | 3.19 |
ENST00000543357.1
|
ARHGEF35
|
Rho guanine nucleotide exchange factor (GEF) 35 |
| chr22_+_30792980 | 3.18 |
ENST00000403484.1
ENST00000405717.3 ENST00000402592.3 |
SEC14L2
|
SEC14-like 2 (S. cerevisiae) |
| chr18_+_21269556 | 3.18 |
ENST00000399516.3
|
LAMA3
|
laminin, alpha 3 |
| chr19_-_14228541 | 3.18 |
ENST00000590853.1
ENST00000308677.4 |
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha |
| chr20_+_45338126 | 3.15 |
ENST00000359271.2
|
SLC2A10
|
solute carrier family 2 (facilitated glucose transporter), member 10 |
| chr6_-_108279369 | 3.14 |
ENST00000369002.4
|
SEC63
|
SEC63 homolog (S. cerevisiae) |
| chr3_-_27525826 | 3.13 |
ENST00000454389.1
ENST00000440156.1 ENST00000437179.1 ENST00000446700.1 ENST00000455077.1 ENST00000435667.2 ENST00000388777.4 ENST00000425128.2 |
SLC4A7
|
solute carrier family 4, sodium bicarbonate cotransporter, member 7 |
| chr18_-_61089611 | 3.12 |
ENST00000591519.1
|
VPS4B
|
vacuolar protein sorting 4 homolog B (S. cerevisiae) |
| chr15_-_44069741 | 3.11 |
ENST00000319359.3
|
ELL3
|
elongation factor RNA polymerase II-like 3 |
| chr4_-_102268708 | 3.06 |
ENST00000525819.1
|
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme |
| chr5_+_148521381 | 3.06 |
ENST00000504238.1
|
ABLIM3
|
actin binding LIM protein family, member 3 |
| chr4_-_90758227 | 3.02 |
ENST00000506691.1
ENST00000394986.1 ENST00000506244.1 ENST00000394989.2 ENST00000394991.3 |
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
| chr12_+_57522692 | 3.00 |
ENST00000554174.1
|
LRP1
|
low density lipoprotein receptor-related protein 1 |
| chr3_+_50192499 | 3.00 |
ENST00000413852.1
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
| chr4_+_1795012 | 2.99 |
ENST00000481110.2
ENST00000340107.4 ENST00000440486.2 ENST00000412135.2 |
FGFR3
|
fibroblast growth factor receptor 3 |
| chr19_+_10765614 | 2.99 |
ENST00000589283.1
|
ILF3
|
interleukin enhancer binding factor 3, 90kDa |
| chr2_-_237416181 | 2.98 |
ENST00000409907.3
|
IQCA1
|
IQ motif containing with AAA domain 1 |
| chrX_+_146993648 | 2.96 |
ENST00000370470.1
|
FMR1
|
fragile X mental retardation 1 |
| chr5_-_81046904 | 2.93 |
ENST00000515395.1
|
SSBP2
|
single-stranded DNA binding protein 2 |
| chr22_+_30792846 | 2.92 |
ENST00000312932.9
ENST00000428195.1 |
SEC14L2
|
SEC14-like 2 (S. cerevisiae) |
| chr3_+_50192537 | 2.91 |
ENST00000002829.3
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
| chr3_-_17783990 | 2.90 |
ENST00000429383.4
ENST00000446863.1 ENST00000414349.1 ENST00000428355.1 ENST00000425944.1 ENST00000445294.1 ENST00000444471.1 ENST00000415814.2 |
TBC1D5
|
TBC1 domain family, member 5 |
| chr1_+_33207381 | 2.90 |
ENST00000401073.2
|
KIAA1522
|
KIAA1522 |
| chr5_+_61601965 | 2.89 |
ENST00000401507.3
|
KIF2A
|
kinesin heavy chain member 2A |
| chr1_+_10093188 | 2.89 |
ENST00000377153.1
|
UBE4B
|
ubiquitination factor E4B |
| chr3_+_133292851 | 2.88 |
ENST00000503932.1
|
CDV3
|
CDV3 homolog (mouse) |
| chr11_-_119599794 | 2.88 |
ENST00000264025.3
|
PVRL1
|
poliovirus receptor-related 1 (herpesvirus entry mediator C) |
| chr5_+_109025067 | 2.87 |
ENST00000261483.4
|
MAN2A1
|
mannosidase, alpha, class 2A, member 1 |
| chr11_+_117947724 | 2.87 |
ENST00000534111.1
|
TMPRSS4
|
transmembrane protease, serine 4 |
| chr3_+_10857885 | 2.87 |
ENST00000254488.2
ENST00000454147.1 |
SLC6A11
|
solute carrier family 6 (neurotransmitter transporter), member 11 |
| chr7_-_143892748 | 2.82 |
ENST00000378115.2
|
ARHGEF35
|
Rho guanine nucleotide exchange factor (GEF) 35 |
| chr7_+_144052381 | 2.81 |
ENST00000498580.1
ENST00000056217.5 |
ARHGEF5
|
Rho guanine nucleotide exchange factor (GEF) 5 |
| chr1_+_60280458 | 2.81 |
ENST00000455990.1
ENST00000371208.3 |
HOOK1
|
hook microtubule-tethering protein 1 |
| chr16_-_65155979 | 2.80 |
ENST00000562325.1
ENST00000268603.4 |
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast) |
| chr22_+_38035459 | 2.80 |
ENST00000357436.4
|
SH3BP1
|
SH3-domain binding protein 1 |
| chr1_+_160175117 | 2.80 |
ENST00000360472.4
|
PEA15
|
phosphoprotein enriched in astrocytes 15 |
| chr17_+_76183398 | 2.80 |
ENST00000409257.5
|
AFMID
|
arylformamidase |
| chr8_-_103424916 | 2.80 |
ENST00000220959.4
|
UBR5
|
ubiquitin protein ligase E3 component n-recognin 5 |
| chr12_-_48152428 | 2.79 |
ENST00000449771.2
ENST00000395358.3 |
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
| chr6_+_43739697 | 2.78 |
ENST00000230480.6
|
VEGFA
|
vascular endothelial growth factor A |
| chr11_-_118134997 | 2.77 |
ENST00000278937.2
|
MPZL2
|
myelin protein zero-like 2 |
| chr14_-_81902791 | 2.77 |
ENST00000557055.1
|
STON2
|
stonin 2 |
| chr3_-_18466026 | 2.75 |
ENST00000417717.2
|
SATB1
|
SATB homeobox 1 |
| chr19_+_45754505 | 2.74 |
ENST00000262891.4
ENST00000300843.4 |
MARK4
|
MAP/microtubule affinity-regulating kinase 4 |
| chr15_-_81616446 | 2.73 |
ENST00000302824.6
|
STARD5
|
StAR-related lipid transfer (START) domain containing 5 |
| chr1_+_36789335 | 2.72 |
ENST00000373137.2
|
RP11-268J15.5
|
RP11-268J15.5 |
| chr2_+_238600788 | 2.71 |
ENST00000289175.6
ENST00000244815.5 |
LRRFIP1
|
leucine rich repeat (in FLII) interacting protein 1 |
| chr17_-_58469687 | 2.71 |
ENST00000590133.1
|
USP32
|
ubiquitin specific peptidase 32 |
| chr1_+_39734131 | 2.70 |
ENST00000530262.1
|
MACF1
|
microtubule-actin crosslinking factor 1 |
| chr1_-_27481401 | 2.69 |
ENST00000263980.3
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 |
| chr17_-_31204124 | 2.69 |
ENST00000579584.1
ENST00000318217.5 ENST00000583621.1 |
MYO1D
|
myosin ID |
| chr12_-_58145889 | 2.68 |
ENST00000547853.1
|
CDK4
|
cyclin-dependent kinase 4 |
| chr14_+_94640671 | 2.67 |
ENST00000328839.3
|
PPP4R4
|
protein phosphatase 4, regulatory subunit 4 |
| chr22_+_38035623 | 2.66 |
ENST00000336738.5
ENST00000442465.2 |
SH3BP1
|
SH3-domain binding protein 1 |
| chr8_+_94929110 | 2.65 |
ENST00000520728.1
|
PDP1
|
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
| chr5_+_137801160 | 2.65 |
ENST00000239938.4
|
EGR1
|
early growth response 1 |
| chr2_-_203103185 | 2.65 |
ENST00000409205.1
|
SUMO1
|
small ubiquitin-like modifier 1 |
| chr1_-_21503337 | 2.63 |
ENST00000400422.1
ENST00000602326.1 ENST00000411888.1 ENST00000438975.1 |
EIF4G3
|
eukaryotic translation initiation factor 4 gamma, 3 |
| chr11_+_34073269 | 2.63 |
ENST00000389645.3
|
CAPRIN1
|
cell cycle associated protein 1 |
| chr1_+_171454639 | 2.63 |
ENST00000392078.3
ENST00000426496.2 |
PRRC2C
|
proline-rich coiled-coil 2C |
| chr1_+_160175201 | 2.62 |
ENST00000368076.1
|
PEA15
|
phosphoprotein enriched in astrocytes 15 |
| chrX_+_53111541 | 2.62 |
ENST00000375442.4
ENST00000579390.1 |
TSPYL2
|
TSPY-like 2 |
| chr1_+_35247859 | 2.60 |
ENST00000373362.3
|
GJB3
|
gap junction protein, beta 3, 31kDa |
| chr12_-_120554534 | 2.60 |
ENST00000538903.1
ENST00000534951.1 |
RAB35
|
RAB35, member RAS oncogene family |
| chr10_-_126107482 | 2.58 |
ENST00000368845.5
ENST00000539214.1 |
OAT
|
ornithine aminotransferase |
| chr14_+_36295638 | 2.57 |
ENST00000543183.1
|
BRMS1L
|
breast cancer metastasis-suppressor 1-like |
| chr10_-_126849588 | 2.56 |
ENST00000411419.2
|
CTBP2
|
C-terminal binding protein 2 |
| chr7_+_20370746 | 2.56 |
ENST00000222573.4
|
ITGB8
|
integrin, beta 8 |
| chr2_+_71693812 | 2.56 |
ENST00000409651.1
ENST00000394120.2 ENST00000409744.1 ENST00000409366.1 ENST00000410020.3 ENST00000410041.1 |
DYSF
|
dysferlin |
| chr11_-_12030130 | 2.55 |
ENST00000450094.2
ENST00000534511.1 |
DKK3
|
dickkopf WNT signaling pathway inhibitor 3 |
| chr11_-_118135160 | 2.54 |
ENST00000438295.2
|
MPZL2
|
myelin protein zero-like 2 |
| chr19_-_10679697 | 2.54 |
ENST00000335766.2
|
CDKN2D
|
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) |
| chr1_+_160175166 | 2.53 |
ENST00000368077.1
|
PEA15
|
phosphoprotein enriched in astrocytes 15 |
| chr11_+_13690249 | 2.53 |
ENST00000532701.1
|
FAR1
|
fatty acyl CoA reductase 1 |
| chr10_+_103911926 | 2.52 |
ENST00000605788.1
ENST00000405356.1 |
NOLC1
|
nucleolar and coiled-body phosphoprotein 1 |
| chr2_-_216300784 | 2.52 |
ENST00000421182.1
ENST00000432072.2 ENST00000323926.6 ENST00000336916.4 ENST00000357867.4 ENST00000359671.1 ENST00000346544.3 ENST00000345488.5 ENST00000357009.2 ENST00000446046.1 ENST00000356005.4 ENST00000443816.1 ENST00000426059.1 ENST00000354785.4 |
FN1
|
fibronectin 1 |
| chr7_-_41740181 | 2.50 |
ENST00000442711.1
|
INHBA
|
inhibin, beta A |
| chr15_-_59041768 | 2.50 |
ENST00000402627.1
ENST00000396140.2 ENST00000559053.1 ENST00000561288.1 |
ADAM10
|
ADAM metallopeptidase domain 10 |
| chr1_-_153581798 | 2.48 |
ENST00000368704.1
ENST00000368705.2 |
S100A16
|
S100 calcium binding protein A16 |
| chr17_+_65821636 | 2.48 |
ENST00000544778.2
|
BPTF
|
bromodomain PHD finger transcription factor |
| chr19_+_10736183 | 2.48 |
ENST00000590857.1
ENST00000588688.1 ENST00000586078.1 |
SLC44A2
|
solute carrier family 44 (choline transporter), member 2 |
| chr14_-_69261310 | 2.47 |
ENST00000336440.3
|
ZFP36L1
|
ZFP36 ring finger protein-like 1 |
| chr6_+_106959718 | 2.45 |
ENST00000369066.3
|
AIM1
|
absent in melanoma 1 |
| chr9_+_71789133 | 2.44 |
ENST00000348208.4
ENST00000265384.7 |
TJP2
|
tight junction protein 2 |
| chr20_-_18038521 | 2.44 |
ENST00000278780.6
|
OVOL2
|
ovo-like zinc finger 2 |
| chr20_-_33413416 | 2.44 |
ENST00000359003.2
|
NCOA6
|
nuclear receptor coactivator 6 |
| chrX_+_100878112 | 2.44 |
ENST00000491568.2
ENST00000479298.1 |
ARMCX3
|
armadillo repeat containing, X-linked 3 |
| chr5_+_148521454 | 2.43 |
ENST00000508983.1
|
ABLIM3
|
actin binding LIM protein family, member 3 |
| chr6_-_35464817 | 2.42 |
ENST00000338863.7
|
TEAD3
|
TEA domain family member 3 |
| chr12_+_107349606 | 2.42 |
ENST00000547242.1
ENST00000551489.1 ENST00000550344.1 |
C12orf23
|
chromosome 12 open reading frame 23 |
| chr1_+_203595903 | 2.42 |
ENST00000367218.3
ENST00000367219.3 ENST00000391954.2 |
ATP2B4
|
ATPase, Ca++ transporting, plasma membrane 4 |
| chr19_+_42212526 | 2.40 |
ENST00000598976.1
ENST00000435837.2 ENST00000221992.6 ENST00000405816.1 |
CEA
CEACAM5
|
Uncharacterized protein carcinoembryonic antigen-related cell adhesion molecule 5 |
| chr3_-_51533966 | 2.40 |
ENST00000504652.1
|
VPRBP
|
Vpr (HIV-1) binding protein |
| chr19_+_11546440 | 2.40 |
ENST00000589126.1
ENST00000588269.1 ENST00000587509.1 ENST00000592741.1 ENST00000593101.1 ENST00000587327.1 |
PRKCSH
|
protein kinase C substrate 80K-H |
| chr5_+_170210721 | 2.39 |
ENST00000265294.4
ENST00000519385.1 ENST00000519598.1 |
GABRP
|
gamma-aminobutyric acid (GABA) A receptor, pi |
| chr7_+_143078652 | 2.38 |
ENST00000354434.4
ENST00000449423.2 |
ZYX
|
zyxin |
| chr11_+_68228186 | 2.37 |
ENST00000393799.2
ENST00000393800.2 ENST00000528635.1 ENST00000533127.1 ENST00000529907.1 ENST00000529344.1 ENST00000534534.1 ENST00000524845.1 ENST00000265637.4 ENST00000524904.1 ENST00000393801.3 ENST00000265636.5 ENST00000529710.1 |
PPP6R3
|
protein phosphatase 6, regulatory subunit 3 |
| chr19_+_19496728 | 2.37 |
ENST00000537887.1
ENST00000417582.2 |
GATAD2A
|
GATA zinc finger domain containing 2A |
| chr3_-_113415441 | 2.37 |
ENST00000491165.1
ENST00000316407.4 |
KIAA2018
|
KIAA2018 |
| chr1_+_210406121 | 2.37 |
ENST00000367012.3
|
SERTAD4
|
SERTA domain containing 4 |
| chr10_-_25012115 | 2.36 |
ENST00000446003.1
|
ARHGAP21
|
Rho GTPase activating protein 21 |
| chr1_+_184356188 | 2.35 |
ENST00000235307.6
|
C1orf21
|
chromosome 1 open reading frame 21 |
| chr11_-_77122928 | 2.35 |
ENST00000528203.1
ENST00000528592.1 ENST00000528633.1 ENST00000529248.1 |
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1 |
| chr6_-_41130914 | 2.34 |
ENST00000373113.3
ENST00000338469.3 |
TREM2
|
triggering receptor expressed on myeloid cells 2 |
| chr4_-_185570590 | 2.33 |
ENST00000517513.1
ENST00000447121.2 ENST00000393588.4 ENST00000308394.4 ENST00000523916.1 |
CASP3
|
caspase 3, apoptosis-related cysteine peptidase |
| chr14_+_65171099 | 2.33 |
ENST00000247226.7
|
PLEKHG3
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 3 |
| chr2_+_219433588 | 2.33 |
ENST00000295701.5
|
RQCD1
|
RCD1 required for cell differentiation1 homolog (S. pombe) |
| chr12_-_51785182 | 2.32 |
ENST00000356317.3
ENST00000603188.1 ENST00000604847.1 ENST00000604506.1 |
GALNT6
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) |
| chr20_-_3219359 | 2.32 |
ENST00000437836.2
|
SLC4A11
|
solute carrier family 4, sodium borate transporter, member 11 |
Network of associatons between targets according to the STRING database.
First level regulatory network of E2F6
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.3 | 6.8 | GO:0015728 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 2.1 | 10.3 | GO:0021623 | optic cup structural organization(GO:0003409) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
| 1.9 | 5.8 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 1.8 | 7.1 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
| 1.7 | 8.3 | GO:0003165 | Purkinje myocyte development(GO:0003165) |
| 1.6 | 13.0 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 1.6 | 1.6 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
| 1.6 | 19.2 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
| 1.6 | 4.8 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
| 1.6 | 6.3 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
| 1.6 | 9.3 | GO:0030421 | defecation(GO:0030421) |
| 1.4 | 4.1 | GO:1901254 | modulation by host of viral RNA genome replication(GO:0044830) positive regulation of intracellular transport of viral material(GO:1901254) |
| 1.4 | 6.8 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 1.3 | 4.0 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 1.3 | 3.9 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
| 1.3 | 3.9 | GO:0033242 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
| 1.3 | 5.1 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 1.3 | 5.1 | GO:1903722 | negative regulation of exosomal secretion(GO:1903542) regulation of centriole elongation(GO:1903722) |
| 1.2 | 13.3 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
| 1.2 | 11.9 | GO:1901315 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
| 1.2 | 3.5 | GO:0021503 | neural fold bending(GO:0021503) |
| 1.2 | 4.7 | GO:0010983 | positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 1.2 | 7.0 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
| 1.2 | 4.7 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
| 1.2 | 1.2 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
| 1.1 | 3.3 | GO:0035508 | positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
| 1.1 | 5.4 | GO:0051541 | elastin metabolic process(GO:0051541) |
| 1.1 | 7.5 | GO:0030035 | microspike assembly(GO:0030035) |
| 1.0 | 3.1 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 1.0 | 3.1 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
| 1.0 | 4.1 | GO:2000173 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 1.0 | 4.0 | GO:0009956 | radial pattern formation(GO:0009956) |
| 1.0 | 1.0 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
| 1.0 | 3.8 | GO:0090094 | metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.9 | 3.7 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.9 | 2.8 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.9 | 3.6 | GO:0060166 | olfactory pit development(GO:0060166) |
| 0.9 | 6.3 | GO:0048102 | autophagic cell death(GO:0048102) |
| 0.9 | 3.6 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.9 | 4.4 | GO:2000470 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
| 0.9 | 8.8 | GO:1990834 | response to odorant(GO:1990834) |
| 0.9 | 4.4 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.8 | 3.4 | GO:0042000 | translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
| 0.8 | 2.5 | GO:1904237 | regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) |
| 0.8 | 4.2 | GO:0033123 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.8 | 0.8 | GO:1990051 | activation of protein kinase C activity(GO:1990051) |
| 0.8 | 5.0 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.8 | 4.2 | GO:1901545 | cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
| 0.8 | 2.5 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.8 | 2.4 | GO:2000742 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.8 | 11.1 | GO:1901166 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 0.8 | 0.8 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
| 0.8 | 1.5 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
| 0.8 | 5.4 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
| 0.8 | 2.3 | GO:1900085 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 0.8 | 2.3 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 0.7 | 4.5 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
| 0.7 | 4.5 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.7 | 2.2 | GO:0086055 | atrial ventricular junction remodeling(GO:0003294) atrial cardiac muscle cell to AV node cell communication by electrical coupling(GO:0086044) bundle of His cell to Purkinje myocyte communication by electrical coupling(GO:0086054) Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling(GO:0086055) regulation of Purkinje myocyte action potential(GO:0098906) vasomotion(GO:1990029) |
| 0.7 | 1.5 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
| 0.7 | 1.4 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
| 0.7 | 2.8 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.7 | 2.1 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 0.7 | 0.7 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
| 0.7 | 2.1 | GO:0050720 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.7 | 2.1 | GO:0033025 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 0.7 | 2.1 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
| 0.7 | 3.4 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.7 | 2.0 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.7 | 4.7 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.7 | 3.4 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
| 0.7 | 4.6 | GO:1902963 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 0.7 | 3.9 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.7 | 2.0 | GO:1903674 | regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
| 0.6 | 1.9 | GO:0052553 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.6 | 0.6 | GO:1901204 | regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) |
| 0.6 | 1.9 | GO:0032240 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.6 | 7.6 | GO:0021759 | globus pallidus development(GO:0021759) |
| 0.6 | 4.4 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.6 | 1.3 | GO:0061647 | histone H3-K9 modification(GO:0061647) |
| 0.6 | 5.0 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.6 | 4.9 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.6 | 0.6 | GO:0021511 | spinal cord patterning(GO:0021511) |
| 0.6 | 3.7 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) |
| 0.6 | 1.8 | GO:0097195 | pilomotor reflex(GO:0097195) |
| 0.6 | 2.3 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 0.6 | 1.2 | GO:0032796 | uropod organization(GO:0032796) |
| 0.6 | 5.7 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.6 | 3.4 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
| 0.6 | 2.3 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.6 | 4.5 | GO:0030578 | PML body organization(GO:0030578) |
| 0.6 | 7.2 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.6 | 3.3 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
| 0.6 | 1.7 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 0.5 | 1.6 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
| 0.5 | 1.6 | GO:0072684 | mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
| 0.5 | 2.2 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.5 | 2.7 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 0.5 | 2.1 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.5 | 4.8 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.5 | 1.6 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.5 | 10.0 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.5 | 4.2 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.5 | 2.1 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
| 0.5 | 1.6 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
| 0.5 | 2.1 | GO:0048880 | sensory system development(GO:0048880) |
| 0.5 | 7.7 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.5 | 3.6 | GO:0034670 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
| 0.5 | 1.0 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 0.5 | 1.5 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
| 0.5 | 2.0 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
| 0.5 | 1.5 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
| 0.5 | 2.4 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.5 | 3.4 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.5 | 4.8 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.5 | 2.4 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.5 | 1.9 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
| 0.5 | 4.7 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.5 | 1.9 | GO:1990927 | vesicle-mediated cholesterol transport(GO:0090119) calcium ion regulated lysosome exocytosis(GO:1990927) |
| 0.5 | 2.8 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 0.5 | 0.9 | GO:0061010 | gall bladder development(GO:0061010) |
| 0.5 | 0.5 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.5 | 16.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.4 | 2.7 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.4 | 1.3 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
| 0.4 | 1.8 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 0.4 | 3.5 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.4 | 1.3 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
| 0.4 | 1.3 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
| 0.4 | 2.6 | GO:0060214 | endocardium formation(GO:0060214) |
| 0.4 | 1.3 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.4 | 2.6 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
| 0.4 | 8.2 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.4 | 0.8 | GO:2001038 | regulation of cellular response to drug(GO:2001038) |
| 0.4 | 2.9 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.4 | 3.3 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
| 0.4 | 1.2 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
| 0.4 | 0.4 | GO:0043534 | blood vessel endothelial cell migration(GO:0043534) |
| 0.4 | 8.2 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.4 | 1.2 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.4 | 2.4 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.4 | 2.4 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.4 | 1.2 | GO:0061193 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 0.4 | 1.2 | GO:0044209 | AMP salvage(GO:0044209) |
| 0.4 | 1.2 | GO:0070632 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 0.4 | 1.2 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.4 | 0.8 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
| 0.4 | 6.3 | GO:0015871 | choline transport(GO:0015871) |
| 0.4 | 8.6 | GO:0071481 | cellular response to X-ray(GO:0071481) |
| 0.4 | 1.2 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.4 | 2.0 | GO:0042633 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
| 0.4 | 1.6 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.4 | 1.2 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
| 0.4 | 2.7 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.4 | 0.8 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.4 | 3.8 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 0.4 | 1.1 | GO:0007387 | anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 0.4 | 1.1 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
| 0.4 | 6.8 | GO:0015816 | glycine transport(GO:0015816) |
| 0.4 | 2.3 | GO:0015744 | tricarboxylic acid transport(GO:0006842) succinate transport(GO:0015744) citrate transport(GO:0015746) succinate transmembrane transport(GO:0071422) |
| 0.4 | 1.1 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.4 | 1.9 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
| 0.4 | 1.5 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.4 | 6.0 | GO:0015074 | DNA integration(GO:0015074) |
| 0.4 | 5.9 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.4 | 1.8 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
| 0.4 | 1.1 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.4 | 5.4 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
| 0.4 | 4.7 | GO:0035089 | establishment of apical/basal cell polarity(GO:0035089) |
| 0.4 | 1.1 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.4 | 3.6 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) negative regulation of hormone biosynthetic process(GO:0032353) negative regulation of steroid hormone biosynthetic process(GO:0090032) |
| 0.4 | 0.4 | GO:0009405 | pathogenesis(GO:0009405) |
| 0.4 | 9.3 | GO:2000404 | regulation of T cell migration(GO:2000404) |
| 0.4 | 1.4 | GO:1900155 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.3 | 3.5 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.3 | 1.0 | GO:0098886 | modification of dendritic spine(GO:0098886) |
| 0.3 | 2.4 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 0.3 | 1.4 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.3 | 0.7 | GO:1902725 | negative regulation of satellite cell differentiation(GO:1902725) |
| 0.3 | 1.0 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
| 0.3 | 2.4 | GO:0031438 | negative regulation of mRNA cleavage(GO:0031438) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
| 0.3 | 2.7 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
| 0.3 | 1.3 | GO:1904978 | regulation of endosome organization(GO:1904978) |
| 0.3 | 1.0 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.3 | 0.3 | GO:0001842 | neural fold formation(GO:0001842) |
| 0.3 | 1.9 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.3 | 0.6 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
| 0.3 | 0.3 | GO:0035878 | nail development(GO:0035878) |
| 0.3 | 1.0 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.3 | 0.6 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
| 0.3 | 3.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.3 | 1.3 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.3 | 2.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.3 | 3.1 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.3 | 1.5 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.3 | 2.8 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
| 0.3 | 5.9 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.3 | 2.4 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.3 | 1.5 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.3 | 0.9 | GO:1904717 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.3 | 2.4 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.3 | 0.9 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.3 | 1.2 | GO:0061582 | intestinal epithelial cell migration(GO:0061582) |
| 0.3 | 1.2 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
| 0.3 | 0.3 | GO:0015960 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.3 | 2.7 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
| 0.3 | 2.6 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 0.3 | 0.9 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
| 0.3 | 7.9 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.3 | 2.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.3 | 0.9 | GO:0002188 | translation reinitiation(GO:0002188) |
| 0.3 | 4.0 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.3 | 0.9 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 0.3 | 0.6 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.3 | 0.6 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
| 0.3 | 1.1 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
| 0.3 | 4.8 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.3 | 1.1 | GO:1903770 | regulation of telomere maintenance via recombination(GO:0032207) negative regulation of telomere maintenance via recombination(GO:0032208) negative regulation of single strand break repair(GO:1903517) negative regulation of beta-galactosidase activity(GO:1903770) telomere single strand break repair(GO:1903823) negative regulation of telomere single strand break repair(GO:1903824) |
| 0.3 | 1.4 | GO:0035936 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.3 | 1.7 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
| 0.3 | 2.0 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.3 | 3.3 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.3 | 1.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.3 | 1.1 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.3 | 0.8 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.3 | 0.8 | GO:0021722 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.3 | 2.7 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 0.3 | 1.6 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.3 | 1.6 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
| 0.3 | 4.5 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.3 | 3.2 | GO:0007000 | nucleolus organization(GO:0007000) |
| 0.3 | 1.1 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.3 | 1.9 | GO:1901377 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
| 0.3 | 1.6 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
| 0.3 | 1.1 | GO:0006788 | heme oxidation(GO:0006788) |
| 0.3 | 1.3 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.3 | 3.9 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.3 | 4.4 | GO:0007614 | short-term memory(GO:0007614) |
| 0.3 | 1.0 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.3 | 4.2 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.3 | 2.3 | GO:0003383 | apical constriction(GO:0003383) |
| 0.3 | 2.3 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.3 | 8.0 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.3 | 1.8 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
| 0.3 | 2.3 | GO:0015820 | leucine transport(GO:0015820) |
| 0.3 | 0.8 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.2 | 5.5 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
| 0.2 | 2.5 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.2 | 1.7 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.2 | 4.5 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.2 | 2.2 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 0.2 | 1.7 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 0.2 | 1.4 | GO:0015961 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.2 | 1.4 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.2 | 0.7 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.2 | 0.7 | GO:0042321 | negative regulation of circadian sleep/wake cycle, sleep(GO:0042321) |
| 0.2 | 1.4 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
| 0.2 | 0.9 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.2 | 0.2 | GO:0015870 | acetylcholine transport(GO:0015870) |
| 0.2 | 1.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.2 | 1.1 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.2 | 0.7 | GO:0016071 | mRNA metabolic process(GO:0016071) |
| 0.2 | 4.6 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
| 0.2 | 1.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.2 | 1.6 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.2 | 0.5 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
| 0.2 | 2.7 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.2 | 0.7 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.2 | 2.0 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.2 | 0.5 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 0.2 | 1.1 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
| 0.2 | 1.1 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
| 0.2 | 1.3 | GO:0072658 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.2 | 0.7 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.2 | 0.7 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
| 0.2 | 0.4 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.2 | 0.9 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.2 | 0.7 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
| 0.2 | 3.7 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.2 | 2.0 | GO:0098722 | asymmetric stem cell division(GO:0098722) |
| 0.2 | 1.3 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.2 | 1.5 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.2 | 3.2 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
| 0.2 | 2.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.2 | 0.9 | GO:0042335 | cuticle development(GO:0042335) |
| 0.2 | 1.9 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
| 0.2 | 2.4 | GO:0072603 | interleukin-5 secretion(GO:0072603) regulation of interleukin-5 secretion(GO:2000662) positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.2 | 1.1 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
| 0.2 | 3.2 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.2 | 1.5 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
| 0.2 | 0.8 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
| 0.2 | 0.4 | GO:1903510 | mucopolysaccharide metabolic process(GO:1903510) |
| 0.2 | 5.6 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.2 | 1.0 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.2 | 1.0 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
| 0.2 | 0.6 | GO:0035038 | female pronucleus assembly(GO:0035038) |
| 0.2 | 4.1 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.2 | 4.8 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.2 | 0.6 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.2 | 2.8 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.2 | 0.6 | GO:0045081 | negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
| 0.2 | 0.6 | GO:0034758 | regulation of iron ion transport(GO:0034756) positive regulation of iron ion transport(GO:0034758) regulation of iron ion transmembrane transport(GO:0034759) positive regulation of iron ion transmembrane transport(GO:0034761) regulation of iron ion import(GO:1900390) regulation of ferrous iron import into cell(GO:1903989) positive regulation of ferrous iron import into cell(GO:1903991) regulation of ferrous iron binding(GO:1904432) positive regulation of ferrous iron binding(GO:1904434) regulation of transferrin receptor binding(GO:1904435) positive regulation of transferrin receptor binding(GO:1904437) regulation of ferrous iron import across plasma membrane(GO:1904438) positive regulation of ferrous iron import across plasma membrane(GO:1904440) |
| 0.2 | 1.0 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
| 0.2 | 2.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.2 | 1.0 | GO:0036302 | atrioventricular canal development(GO:0036302) |
| 0.2 | 0.6 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 0.2 | 1.9 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
| 0.2 | 0.9 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
| 0.2 | 0.8 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.2 | 0.9 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.2 | 2.0 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
| 0.2 | 0.6 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.2 | 2.2 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.2 | 38.3 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
| 0.2 | 0.5 | GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 0.2 | 1.4 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.2 | 0.9 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
| 0.2 | 0.5 | GO:0090222 | centrosome-templated microtubule nucleation(GO:0090222) |
| 0.2 | 0.4 | GO:0046959 | habituation(GO:0046959) |
| 0.2 | 2.7 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.2 | 0.4 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.2 | 1.8 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
| 0.2 | 0.5 | GO:0048625 | myoblast fate commitment(GO:0048625) |
| 0.2 | 1.4 | GO:0032439 | endosome localization(GO:0032439) |
| 0.2 | 4.4 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
| 0.2 | 2.4 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.2 | 1.4 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.2 | 1.0 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
| 0.2 | 2.5 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.2 | 0.8 | GO:0019563 | glycerol catabolic process(GO:0019563) |
| 0.2 | 0.7 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.2 | 0.3 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
| 0.2 | 0.5 | GO:1904528 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
| 0.2 | 3.8 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.2 | 4.5 | GO:0061157 | mRNA destabilization(GO:0061157) |
| 0.2 | 1.2 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.2 | 5.7 | GO:0060674 | placenta blood vessel development(GO:0060674) |
| 0.2 | 0.8 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.2 | 0.5 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.2 | 3.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
| 0.2 | 1.1 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.2 | 0.8 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
| 0.2 | 2.7 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.2 | 1.3 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) |
| 0.2 | 1.3 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.2 | 0.5 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.2 | 0.5 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.2 | 2.7 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
| 0.2 | 3.0 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 0.2 | 1.2 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
| 0.2 | 3.1 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
| 0.2 | 1.7 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.2 | 0.6 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.2 | 3.7 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
| 0.2 | 4.0 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
| 0.2 | 0.8 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.2 | 1.5 | GO:0071499 | cellular response to laminar fluid shear stress(GO:0071499) |
| 0.2 | 2.0 | GO:0007172 | signal complex assembly(GO:0007172) |
| 0.1 | 0.9 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
| 0.1 | 0.3 | GO:0097107 | postsynaptic density organization(GO:0097106) postsynaptic density assembly(GO:0097107) gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 0.1 | 3.7 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.1 | 1.9 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.1 | 1.9 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 0.1 | 0.7 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
| 0.1 | 1.6 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.1 | 0.9 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.1 | 0.6 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
| 0.1 | 3.2 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.1 | 1.0 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.1 | 1.2 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.1 | 3.5 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.1 | 0.9 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.1 | 1.2 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.1 | 1.3 | GO:0060751 | branch elongation involved in mammary gland duct branching(GO:0060751) |
| 0.1 | 2.4 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.1 | 0.4 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.1 | 1.0 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.1 | 0.3 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
| 0.1 | 1.6 | GO:0003263 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) |
| 0.1 | 0.8 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.1 | 3.0 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 | 1.1 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
| 0.1 | 1.3 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
| 0.1 | 2.5 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.1 | 1.8 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.1 | 0.7 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.1 | 0.4 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) |
| 0.1 | 7.0 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
| 0.1 | 0.5 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
| 0.1 | 0.4 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.1 | 2.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.1 | 0.4 | GO:0061055 | myotome development(GO:0061055) |
| 0.1 | 1.1 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
| 0.1 | 2.8 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.1 | 0.5 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
| 0.1 | 0.5 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.1 | 3.1 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
| 0.1 | 1.0 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
| 0.1 | 2.6 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.1 | 0.5 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
| 0.1 | 0.5 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.1 | 4.0 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.1 | 1.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.1 | 3.5 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.1 | 1.3 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
| 0.1 | 0.5 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
| 0.1 | 1.0 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.1 | 1.4 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.1 | 0.5 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
| 0.1 | 6.3 | GO:0097503 | sialylation(GO:0097503) |
| 0.1 | 7.1 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
| 0.1 | 1.0 | GO:0009636 | response to toxic substance(GO:0009636) |
| 0.1 | 0.4 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.1 | 2.8 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
| 0.1 | 0.4 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.1 | 1.9 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.1 | 4.0 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
| 0.1 | 0.2 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
| 0.1 | 0.5 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.1 | 0.6 | GO:0040034 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
| 0.1 | 0.4 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.1 | 0.4 | GO:0019085 | early viral transcription(GO:0019085) |
| 0.1 | 0.9 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 | 0.6 | GO:0003095 | pressure natriuresis(GO:0003095) |
| 0.1 | 0.9 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.1 | 0.6 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
| 0.1 | 2.2 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.1 | 2.6 | GO:0010842 | retina layer formation(GO:0010842) |
| 0.1 | 4.1 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
| 0.1 | 1.7 | GO:0001502 | cartilage condensation(GO:0001502) |
| 0.1 | 1.1 | GO:0070141 | response to UV-A(GO:0070141) |
| 0.1 | 1.0 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.1 | 1.2 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.1 | 0.5 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
| 0.1 | 0.4 | GO:0070988 | demethylation(GO:0070988) |
| 0.1 | 24.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.1 | 1.2 | GO:0006278 | RNA-dependent DNA biosynthetic process(GO:0006278) |
| 0.1 | 0.3 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.1 | 1.1 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
| 0.1 | 0.8 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.1 | 2.5 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
| 0.1 | 0.4 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 0.1 | 0.6 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
| 0.1 | 0.8 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
| 0.1 | 1.3 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 0.1 | 0.3 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
| 0.1 | 1.8 | GO:0030913 | paranodal junction assembly(GO:0030913) |
| 0.1 | 3.5 | GO:0060074 | synapse maturation(GO:0060074) |
| 0.1 | 0.8 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.1 | 1.8 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.1 | 5.2 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
| 0.1 | 0.4 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.1 | 0.5 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.1 | 0.5 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
| 0.1 | 0.8 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.1 | 0.8 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 | 0.6 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 0.1 | 0.4 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
| 0.1 | 2.5 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.1 | 1.2 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
| 0.1 | 5.4 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
| 0.1 | 0.3 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
| 0.1 | 1.1 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.1 | 1.8 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
| 0.1 | 1.7 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.1 | 1.1 | GO:0060013 | righting reflex(GO:0060013) |
| 0.1 | 0.4 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.1 | 1.9 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.1 | 1.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.1 | 0.6 | GO:0030047 | actin modification(GO:0030047) |
| 0.1 | 0.4 | GO:0032474 | otolith morphogenesis(GO:0032474) otolith development(GO:0048840) |
| 0.1 | 1.3 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
| 0.1 | 0.3 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.1 | 3.5 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
| 0.1 | 0.3 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
| 0.1 | 0.7 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
| 0.1 | 0.5 | GO:0032025 | response to cobalt ion(GO:0032025) |
| 0.1 | 2.8 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 | 2.8 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.1 | 1.8 | GO:0007141 | male meiosis I(GO:0007141) |
| 0.1 | 0.3 | GO:0060965 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) |
| 0.1 | 0.6 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 0.1 | 0.4 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 | 0.3 | GO:0021795 | cerebral cortex cell migration(GO:0021795) |
| 0.1 | 2.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.1 | 2.2 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) |
| 0.1 | 0.9 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.1 | 1.5 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
| 0.1 | 1.0 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.1 | 0.9 | GO:0009642 | response to light intensity(GO:0009642) |
| 0.1 | 0.4 | GO:2000690 | regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.1 | 2.4 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.1 | 1.1 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
| 0.1 | 0.9 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.1 | 8.0 | GO:0030819 | positive regulation of cAMP biosynthetic process(GO:0030819) |
| 0.1 | 1.1 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
| 0.1 | 0.1 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
| 0.1 | 0.1 | GO:0071231 | cellular response to folic acid(GO:0071231) |
| 0.1 | 0.4 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.1 | 0.5 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 0.1 | 0.9 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.1 | 0.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.1 | 0.5 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
| 0.1 | 1.5 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 | 0.3 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.1 | 0.2 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
| 0.1 | 0.1 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
| 0.1 | 0.5 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.1 | 0.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
| 0.1 | 0.2 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
| 0.1 | 0.5 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.1 | 0.7 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.1 | 1.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.1 | 0.4 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.1 | 0.7 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.1 | 2.0 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.1 | 0.6 | GO:0006293 | nucleotide-excision repair, preincision complex stabilization(GO:0006293) |
| 0.1 | 0.3 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
| 0.1 | 1.2 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.1 | 3.0 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.1 | 0.3 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 0.1 | 0.8 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 | 0.9 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.1 | 0.2 | GO:0032223 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.1 | 0.2 | GO:0032912 | endodermal cell fate determination(GO:0007493) negative regulation of transforming growth factor beta2 production(GO:0032912) |
| 0.1 | 1.6 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.1 | 0.6 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.1 | 0.5 | GO:0030099 | myeloid cell differentiation(GO:0030099) |
| 0.1 | 0.9 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
| 0.1 | 2.5 | GO:1990090 | response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
| 0.1 | 0.2 | GO:0098939 | dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
| 0.1 | 1.2 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
| 0.1 | 0.1 | GO:0021586 | olfactory learning(GO:0008355) pons maturation(GO:0021586) |
| 0.1 | 0.9 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
| 0.1 | 0.6 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.1 | 6.3 | GO:0030032 | lamellipodium assembly(GO:0030032) |
| 0.1 | 0.6 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
| 0.1 | 0.4 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
| 0.1 | 1.3 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.1 | 0.7 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.1 | 0.5 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.1 | 1.2 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.1 | 0.3 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.1 | 0.4 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.1 | 0.3 | GO:0048749 | compound eye development(GO:0048749) |
| 0.1 | 0.5 | GO:0007512 | adult heart development(GO:0007512) |
| 0.1 | 2.5 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.1 | 0.1 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
| 0.1 | 1.5 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
| 0.1 | 0.1 | GO:1990535 | neuron projection maintenance(GO:1990535) |
| 0.1 | 0.4 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
| 0.1 | 0.3 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.1 | 1.6 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
| 0.1 | 1.8 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.1 | 1.9 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
| 0.1 | 4.3 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.1 | 0.5 | GO:0030916 | otic vesicle formation(GO:0030916) |
| 0.1 | 0.3 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) regulation of actin nucleation(GO:0051125) |
| 0.1 | 0.5 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.1 | 0.5 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
| 0.1 | 0.2 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
| 0.1 | 0.4 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.1 | 0.3 | GO:0034378 | chylomicron assembly(GO:0034378) |
| 0.1 | 0.3 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
| 0.1 | 1.2 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.1 | 0.9 | GO:0048041 | cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
| 0.1 | 1.2 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) |
| 0.1 | 0.3 | GO:0008356 | asymmetric cell division(GO:0008356) |
| 0.1 | 1.0 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.1 | 0.3 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.1 | 0.8 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.1 | 0.4 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.1 | 0.4 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.1 | 0.3 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.1 | 4.1 | GO:0015914 | phospholipid transport(GO:0015914) |
| 0.1 | 4.3 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.1 | 4.3 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
| 0.1 | 0.2 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
| 0.1 | 1.9 | GO:0007020 | microtubule nucleation(GO:0007020) |
| 0.1 | 0.5 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.1 | 0.5 | GO:2001268 | urokinase plasminogen activator signaling pathway(GO:0038195) negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.1 | 0.7 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 | 0.4 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.1 | 1.4 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.1 | 0.6 | GO:0071625 | vocalization behavior(GO:0071625) |
| 0.1 | 1.9 | GO:0042044 | fluid transport(GO:0042044) |
| 0.1 | 0.2 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.1 | 0.4 | GO:0035567 | non-canonical Wnt signaling pathway(GO:0035567) |
| 0.1 | 0.5 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.1 | 0.8 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.1 | 0.5 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.1 | 0.9 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.1 | 3.5 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
| 0.1 | 0.6 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.1 | 0.6 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.1 | 0.9 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
| 0.1 | 1.4 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) glucocorticoid receptor signaling pathway(GO:0042921) |
| 0.1 | 1.3 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.1 | 0.5 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
| 0.1 | 0.3 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 | 2.7 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
| 0.1 | 0.1 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.1 | 0.6 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 0.1 | 0.4 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 0.1 | 0.3 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 0.1 | 0.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.0 | 8.8 | GO:0002576 | platelet degranulation(GO:0002576) |
| 0.0 | 0.5 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.0 | 0.1 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 0.0 | 0.5 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
| 0.0 | 0.9 | GO:0006623 | protein targeting to vacuole(GO:0006623) |
| 0.0 | 5.6 | GO:0016575 | histone deacetylation(GO:0016575) |
| 0.0 | 1.1 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
| 0.0 | 0.2 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
| 0.0 | 0.2 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
| 0.0 | 0.8 | GO:0097581 | lamellipodium organization(GO:0097581) |
| 0.0 | 0.9 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.0 | 0.2 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.0 | 0.1 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
| 0.0 | 0.7 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.0 | 0.4 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.0 | 0.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.0 | 0.8 | GO:0090220 | telomere localization(GO:0034397) chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
| 0.0 | 0.3 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.0 | 0.6 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.0 | 0.6 | GO:0015705 | iodide transport(GO:0015705) |
| 0.0 | 1.0 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
| 0.0 | 1.1 | GO:0006027 | aminoglycan catabolic process(GO:0006026) glycosaminoglycan catabolic process(GO:0006027) |
| 0.0 | 0.4 | GO:0034599 | cellular response to oxidative stress(GO:0034599) |
| 0.0 | 0.3 | GO:1903365 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) muscle cell fate determination(GO:0007521) regulation of fear response(GO:1903365) positive regulation of fear response(GO:1903367) regulation of behavioral fear response(GO:2000822) positive regulation of behavioral fear response(GO:2000987) |
| 0.0 | 0.2 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
| 0.0 | 2.0 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 | 0.2 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
| 0.0 | 2.4 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.0 | 0.2 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
| 0.0 | 0.1 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
| 0.0 | 0.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 | 0.7 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
| 0.0 | 0.1 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
| 0.0 | 4.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.0 | 0.3 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
| 0.0 | 0.2 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
| 0.0 | 0.3 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
| 0.0 | 0.3 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
| 0.0 | 0.1 | GO:0033058 | directional locomotion(GO:0033058) |
| 0.0 | 0.7 | GO:0070828 | heterochromatin organization(GO:0070828) |
| 0.0 | 0.1 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
| 0.0 | 0.8 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.0 | 0.5 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.0 | 0.1 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
| 0.0 | 0.6 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
| 0.0 | 0.2 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.0 | 0.1 | GO:0033320 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
| 0.0 | 0.6 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.0 | 0.5 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
| 0.0 | 0.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.0 | 0.8 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.0 | 2.2 | GO:0006901 | vesicle coating(GO:0006901) vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
| 0.0 | 0.2 | GO:0019076 | viral release from host cell(GO:0019076) |
| 0.0 | 0.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.0 | 0.5 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
| 0.0 | 0.2 | GO:0002347 | response to tumor cell(GO:0002347) |
| 0.0 | 2.1 | GO:0090109 | regulation of focal adhesion assembly(GO:0051893) regulation of cell-substrate junction assembly(GO:0090109) |
| 0.0 | 1.4 | GO:0042407 | cristae formation(GO:0042407) |
| 0.0 | 2.4 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.0 | 0.2 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.0 | 0.5 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
| 0.0 | 1.2 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.0 | 0.2 | GO:0035411 | catenin import into nucleus(GO:0035411) regulation of catenin import into nucleus(GO:0035412) |
| 0.0 | 0.2 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.0 | 0.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.0 | 0.2 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
| 0.0 | 0.3 | GO:0034465 | response to carbon monoxide(GO:0034465) |
| 0.0 | 0.6 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.0 | 0.6 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
| 0.0 | 0.4 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.0 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 0.0 | 0.1 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.0 | 0.7 | GO:1903432 | regulation of TORC1 signaling(GO:1903432) |
| 0.0 | 0.7 | GO:0043966 | histone H3 acetylation(GO:0043966) |
| 0.0 | 0.3 | GO:0001832 | blastocyst growth(GO:0001832) inner cell mass cell proliferation(GO:0001833) |
| 0.0 | 0.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.0 | 0.2 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.0 | 1.8 | GO:0009584 | detection of visible light(GO:0009584) |
| 0.0 | 0.1 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.0 | 1.8 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 | 0.1 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.0 | 0.5 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.0 | 0.2 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
| 0.0 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 0.0 | 0.5 | GO:0006884 | cell volume homeostasis(GO:0006884) |
| 0.0 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.0 | 1.3 | GO:0035036 | sperm-egg recognition(GO:0035036) |
| 0.0 | 0.1 | GO:0006568 | tryptophan metabolic process(GO:0006568) |
| 0.0 | 0.2 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) negative regulation of translational initiation in response to stress(GO:0032057) |
| 0.0 | 0.4 | GO:0019079 | viral genome replication(GO:0019079) |
| 0.0 | 0.1 | GO:0030320 | cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.0 | 0.4 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.0 | 1.0 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
| 0.0 | 2.3 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
| 0.0 | 0.3 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.0 | 0.8 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.0 | 0.1 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
| 0.0 | 0.2 | GO:0007140 | male meiosis(GO:0007140) |
| 0.0 | 0.5 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
| 0.0 | 0.5 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
| 0.0 | 0.2 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.0 | 0.0 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
| 0.0 | 0.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.0 | 1.2 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
| 0.0 | 0.7 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.0 | 0.8 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.0 | 0.5 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 0.0 | 0.8 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
| 0.0 | 1.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 | 0.4 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
| 0.0 | 0.3 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.0 | 0.1 | GO:0030581 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.0 | 0.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.0 | 0.1 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.0 | 0.3 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
| 0.0 | 1.1 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.0 | 0.2 | GO:0015874 | norepinephrine transport(GO:0015874) |
| 0.0 | 0.3 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.0 | 0.3 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
| 0.0 | 0.1 | GO:0014805 | regulation of muscle hyperplasia(GO:0014738) negative regulation of muscle hyperplasia(GO:0014740) smooth muscle adaptation(GO:0014805) smooth muscle hyperplasia(GO:0014806) muscle hyperplasia(GO:0014900) |
| 0.0 | 0.3 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.0 | 0.4 | GO:0006397 | mRNA processing(GO:0006397) |
| 0.0 | 0.7 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.0 | 0.1 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
| 0.0 | 0.2 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
| 0.0 | 0.0 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
| 0.0 | 0.1 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.0 | 0.4 | GO:0006809 | nitric oxide biosynthetic process(GO:0006809) |
| 0.0 | 0.0 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
| 0.0 | 0.4 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
| 0.0 | 0.3 | GO:0007338 | single fertilization(GO:0007338) |
| 0.0 | 0.2 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.0 | 0.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
| 0.0 | 0.0 | GO:0002249 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.0 | 0.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
| 0.0 | 0.3 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.0 | 0.2 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
| 0.0 | 0.0 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
| 0.0 | 0.2 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.0 | 0.2 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.0 | 0.0 | GO:0003360 | brainstem development(GO:0003360) |
| 0.0 | 0.1 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.0 | 0.1 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 0.0 | 0.3 | GO:1901998 | toxin transport(GO:1901998) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.0 | 6.0 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 1.6 | 19.2 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 1.4 | 4.1 | GO:1902737 | dendritic filopodium(GO:1902737) |
| 1.0 | 7.9 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.9 | 9.7 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.9 | 3.5 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
| 0.9 | 5.1 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.8 | 2.5 | GO:0043512 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
| 0.8 | 6.3 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.7 | 2.1 | GO:0031213 | RSF complex(GO:0031213) |
| 0.7 | 7.1 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.7 | 1.3 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 0.6 | 11.2 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.6 | 6.8 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.6 | 1.7 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 0.6 | 6.3 | GO:0016589 | NURF complex(GO:0016589) |
| 0.6 | 1.7 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.5 | 2.7 | GO:0071942 | XPC complex(GO:0071942) |
| 0.5 | 1.6 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.5 | 2.6 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 0.5 | 3.6 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
| 0.4 | 2.6 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
| 0.4 | 1.7 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.4 | 3.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.4 | 4.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.4 | 16.9 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.4 | 1.2 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
| 0.4 | 16.1 | GO:0030057 | desmosome(GO:0030057) |
| 0.4 | 10.3 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.4 | 1.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.4 | 1.5 | GO:0031251 | PAN complex(GO:0031251) |
| 0.4 | 2.9 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 0.4 | 1.1 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
| 0.4 | 5.3 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.4 | 1.1 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.4 | 2.8 | GO:0070695 | FHF complex(GO:0070695) |
| 0.3 | 1.0 | GO:0097444 | spine apparatus(GO:0097444) |
| 0.3 | 2.7 | GO:0071203 | WASH complex(GO:0071203) |
| 0.3 | 0.3 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
| 0.3 | 3.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.3 | 1.3 | GO:0031592 | centrosomal corona(GO:0031592) |
| 0.3 | 1.0 | GO:0008623 | CHRAC(GO:0008623) |
| 0.3 | 1.8 | GO:0097513 | myosin II filament(GO:0097513) |
| 0.3 | 3.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.3 | 1.4 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 0.3 | 2.6 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
| 0.3 | 1.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.3 | 10.9 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.3 | 10.8 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.3 | 5.5 | GO:0090543 | Flemming body(GO:0090543) |
| 0.3 | 3.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.3 | 3.3 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.3 | 1.3 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
| 0.3 | 8.3 | GO:0070822 | Sin3-type complex(GO:0070822) |
| 0.3 | 5.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.3 | 1.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.3 | 1.8 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.3 | 1.3 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.3 | 1.8 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.3 | 1.8 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.3 | 2.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.3 | 2.0 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.2 | 3.7 | GO:0045179 | apical cortex(GO:0045179) |
| 0.2 | 9.0 | GO:0071437 | invadopodium(GO:0071437) |
| 0.2 | 7.5 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
| 0.2 | 0.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.2 | 4.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.2 | 1.2 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.2 | 2.0 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 0.2 | 1.1 | GO:0034753 | nuclear aryl hydrocarbon receptor complex(GO:0034753) |
| 0.2 | 3.5 | GO:0032039 | integrator complex(GO:0032039) |
| 0.2 | 3.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.2 | 3.7 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.2 | 0.6 | GO:0005745 | m-AAA complex(GO:0005745) |
| 0.2 | 0.9 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.2 | 3.0 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.2 | 6.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.2 | 4.2 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.2 | 3.6 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.2 | 0.8 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.2 | 0.8 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
| 0.2 | 0.6 | GO:0033011 | perinuclear theca(GO:0033011) |
| 0.2 | 1.0 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
| 0.2 | 1.4 | GO:0005767 | secondary lysosome(GO:0005767) autolysosome(GO:0044754) |
| 0.2 | 1.8 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.2 | 0.6 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.2 | 6.0 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.2 | 1.5 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.2 | 0.6 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
| 0.2 | 1.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.2 | 3.1 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.2 | 1.1 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
| 0.2 | 5.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.2 | 3.0 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.2 | 0.8 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
| 0.2 | 4.5 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.2 | 1.4 | GO:0051286 | cell tip(GO:0051286) |
| 0.2 | 1.2 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.2 | 0.7 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.2 | 4.1 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.2 | 0.2 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.2 | 4.8 | GO:0031045 | dense core granule(GO:0031045) |
| 0.2 | 5.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.2 | 2.5 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.2 | 0.7 | GO:0070939 | Dsl1p complex(GO:0070939) RZZ complex(GO:1990423) |
| 0.2 | 2.3 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.2 | 0.5 | GO:0036398 | TCR signalosome(GO:0036398) |
| 0.2 | 1.9 | GO:0032797 | SMN complex(GO:0032797) |
| 0.2 | 0.9 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
| 0.2 | 4.2 | GO:0005922 | connexon complex(GO:0005922) |
| 0.1 | 1.3 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.1 | 0.6 | GO:0005776 | autophagosome(GO:0005776) |
| 0.1 | 2.0 | GO:0005921 | gap junction(GO:0005921) |
| 0.1 | 2.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.1 | 1.1 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
| 0.1 | 0.6 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) catenin-TCF7L2 complex(GO:0071664) |
| 0.1 | 1.9 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.1 | 1.8 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 0.1 | 1.5 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.1 | 0.7 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.1 | 3.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.1 | 6.4 | GO:0090544 | BAF-type complex(GO:0090544) |
| 0.1 | 1.6 | GO:0008091 | spectrin(GO:0008091) |
| 0.1 | 2.7 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.1 | 0.6 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 0.1 | 1.6 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.1 | 0.5 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
| 0.1 | 3.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.1 | 0.5 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.1 | 18.0 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.1 | 0.7 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.1 | 1.5 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.1 | 1.7 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.1 | 2.1 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.1 | 2.8 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.1 | 17.6 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.1 | 3.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.1 | 2.5 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.1 | 0.9 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.1 | 4.3 | GO:0043034 | costamere(GO:0043034) |
| 0.1 | 0.6 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.1 | 0.9 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
| 0.1 | 0.9 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.1 | 2.7 | GO:0000974 | Prp19 complex(GO:0000974) |
| 0.1 | 0.4 | GO:0005713 | recombination nodule(GO:0005713) |
| 0.1 | 0.9 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.1 | 0.4 | GO:0071014 | U2-type post-mRNA release spliceosomal complex(GO:0071008) post-mRNA release spliceosomal complex(GO:0071014) |
| 0.1 | 3.9 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.1 | 0.6 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.1 | 1.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.1 | 0.9 | GO:0097413 | Lewy body(GO:0097413) |
| 0.1 | 3.2 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.1 | 3.0 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.1 | 0.9 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
| 0.1 | 5.7 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
| 0.1 | 1.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.1 | 3.5 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.1 | 2.3 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.1 | 8.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.1 | 13.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.1 | 8.8 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
| 0.1 | 3.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.1 | 1.5 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.1 | 0.6 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
| 0.1 | 1.5 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.1 | 1.6 | GO:0032432 | actin filament bundle(GO:0032432) |
| 0.1 | 10.5 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
| 0.1 | 0.3 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 0.1 | 0.4 | GO:0097224 | sperm connecting piece(GO:0097224) |
| 0.1 | 1.2 | GO:0045180 | basal cortex(GO:0045180) |
| 0.1 | 5.1 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.1 | 1.6 | GO:0005770 | late endosome(GO:0005770) |
| 0.1 | 17.4 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.1 | 1.5 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
| 0.1 | 4.6 | GO:0002102 | podosome(GO:0002102) |
| 0.1 | 1.0 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.1 | 1.9 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.1 | 3.6 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.1 | 39.0 | GO:0016607 | nuclear speck(GO:0016607) |
| 0.1 | 4.2 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.1 | 0.9 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.1 | 10.9 | GO:0016605 | PML body(GO:0016605) |
| 0.1 | 1.6 | GO:0030118 | clathrin coat(GO:0030118) |
| 0.1 | 38.4 | GO:0005911 | cell-cell junction(GO:0005911) |
| 0.1 | 0.4 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.1 | 26.4 | GO:0016604 | nuclear body(GO:0016604) |
| 0.1 | 2.0 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.1 | 1.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.1 | 0.9 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.1 | 0.2 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.1 | 0.2 | GO:0039714 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
| 0.1 | 0.8 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.1 | 1.0 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.1 | 0.3 | GO:0000243 | commitment complex(GO:0000243) |
| 0.1 | 0.2 | GO:0070877 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
| 0.1 | 14.5 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.1 | 0.2 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.1 | 0.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.1 | 1.1 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.1 | 2.0 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.1 | 0.5 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 0.1 | 0.4 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.1 | 0.6 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.1 | 0.9 | GO:0099738 | cell cortex region(GO:0099738) |
| 0.1 | 0.4 | GO:0090576 | transcription factor TFIIIC complex(GO:0000127) RNA polymerase III transcription factor complex(GO:0090576) |
| 0.0 | 0.8 | GO:0000235 | astral microtubule(GO:0000235) aster(GO:0005818) |
| 0.0 | 0.1 | GO:0005584 | collagen type I trimer(GO:0005584) |
| 0.0 | 0.1 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
| 0.0 | 0.5 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.0 | 0.2 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
| 0.0 | 0.7 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.0 | 1.0 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.0 | 2.4 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.0 | 2.8 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.0 | 0.7 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.0 | 0.3 | GO:0031415 | NatA complex(GO:0031415) |
| 0.0 | 0.2 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.0 | 0.4 | GO:0005884 | actin filament(GO:0005884) |
| 0.0 | 0.5 | GO:0000800 | lateral element(GO:0000800) |
| 0.0 | 0.6 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
| 0.0 | 0.8 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.0 | 0.8 | GO:1990752 | microtubule end(GO:1990752) |
| 0.0 | 0.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.0 | 0.2 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.0 | 0.2 | GO:0035339 | SPOTS complex(GO:0035339) |
| 0.0 | 0.1 | GO:0032280 | symmetric synapse(GO:0032280) |
| 0.0 | 0.1 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
| 0.0 | 1.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.0 | 1.0 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.0 | 0.2 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.0 | 2.2 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.0 | 0.3 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.0 | 0.4 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
| 0.0 | 0.8 | GO:0005865 | striated muscle thin filament(GO:0005865) |
| 0.0 | 0.1 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.0 | 0.9 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.0 | 0.3 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
| 0.0 | 3.8 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.0 | 0.5 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.0 | 0.2 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.0 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.0 | 0.3 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.0 | 0.6 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.0 | 0.8 | GO:0000502 | proteasome complex(GO:0000502) |
| 0.0 | 3.0 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.0 | 0.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.0 | 0.3 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
| 0.0 | 1.2 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.0 | 0.1 | GO:0001534 | radial spoke(GO:0001534) |
| 0.0 | 0.1 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.0 | 0.2 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.0 | 0.1 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 0.0 | 1.6 | GO:0010008 | endosome membrane(GO:0010008) |
| 0.0 | 1.9 | GO:0031091 | platelet alpha granule(GO:0031091) |
| 0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) piP-body(GO:0071547) |
| 0.0 | 0.1 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.0 | 0.6 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.0 | 1.9 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.0 | 0.1 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.0 | 0.4 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
| 0.0 | 0.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.0 | 0.5 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
| 0.0 | 0.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.0 | 1.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.0 | 0.3 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.0 | 0.1 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.0 | 0.5 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.0 | 0.1 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.0 | 0.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.0 | 0.5 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.0 | 0.3 | GO:0005902 | microvillus(GO:0005902) |
| 0.0 | 0.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.0 | 0.2 | GO:0005903 | brush border(GO:0005903) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.3 | 6.8 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
| 2.3 | 6.8 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
| 2.1 | 6.3 | GO:0086040 | sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086040) |
| 2.0 | 6.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 1.7 | 9.9 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 1.5 | 6.1 | GO:0008431 | vitamin E binding(GO:0008431) |
| 1.4 | 9.9 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 1.3 | 3.9 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
| 1.1 | 7.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 1.0 | 3.1 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
| 1.0 | 22.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.9 | 2.8 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
| 0.9 | 10.6 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.9 | 4.4 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
| 0.9 | 7.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.9 | 7.9 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.9 | 5.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.8 | 18.9 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.8 | 2.3 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 0.8 | 2.3 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 0.7 | 11.9 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.7 | 4.4 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.7 | 2.2 | GO:0086079 | gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling(GO:0086076) gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling(GO:0086078) gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling(GO:0086079) |
| 0.7 | 4.8 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.7 | 2.7 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
| 0.6 | 1.9 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
| 0.6 | 2.3 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.6 | 1.7 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.6 | 2.2 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) phosphatidate cytidylyltransferase activity(GO:0004605) |
| 0.5 | 1.1 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
| 0.5 | 5.9 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.5 | 1.6 | GO:0005365 | myo-inositol transmembrane transporter activity(GO:0005365) |
| 0.5 | 0.5 | GO:0000403 | Y-form DNA binding(GO:0000403) double-strand/single-strand DNA junction binding(GO:0000406) dinucleotide insertion or deletion binding(GO:0032139) single guanine insertion binding(GO:0032142) dinucleotide repeat insertion binding(GO:0032181) |
| 0.5 | 4.4 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.5 | 12.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.5 | 1.5 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
| 0.5 | 1.9 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.5 | 2.9 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.5 | 1.9 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
| 0.5 | 1.9 | GO:0015207 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
| 0.5 | 6.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.5 | 1.9 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.5 | 4.6 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.5 | 2.8 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 0.5 | 1.8 | GO:0052590 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 0.5 | 6.8 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.4 | 4.0 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 0.4 | 1.8 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.4 | 1.3 | GO:0047322 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
| 0.4 | 3.9 | GO:0042610 | CD8 receptor binding(GO:0042610) |
| 0.4 | 2.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.4 | 4.8 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.4 | 1.7 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.4 | 2.1 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
| 0.4 | 1.3 | GO:0008746 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
| 0.4 | 2.9 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
| 0.4 | 5.4 | GO:0031386 | protein tag(GO:0031386) |
| 0.4 | 2.5 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 0.4 | 4.6 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.4 | 1.6 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
| 0.4 | 4.5 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 0.4 | 1.6 | GO:1902379 | receptor tyrosine kinase-like orphan receptor binding(GO:0005115) chemoattractant activity involved in axon guidance(GO:1902379) |
| 0.4 | 8.8 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.4 | 3.6 | GO:1990763 | arrestin family protein binding(GO:1990763) |
| 0.4 | 1.2 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 0.4 | 2.3 | GO:0017153 | citrate transmembrane transporter activity(GO:0015137) succinate transmembrane transporter activity(GO:0015141) tricarboxylic acid transmembrane transporter activity(GO:0015142) sodium:dicarboxylate symporter activity(GO:0017153) |
| 0.4 | 2.6 | GO:0051748 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
| 0.4 | 4.5 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.4 | 1.5 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
| 0.4 | 1.9 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
| 0.4 | 15.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.4 | 5.5 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
| 0.4 | 2.6 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.4 | 1.5 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.4 | 4.0 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.4 | 6.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.4 | 5.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.4 | 5.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.4 | 2.9 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
| 0.4 | 4.2 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.3 | 1.0 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
| 0.3 | 3.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.3 | 3.0 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.3 | 2.0 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 0.3 | 4.7 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.3 | 1.3 | GO:0035939 | microsatellite binding(GO:0035939) |
| 0.3 | 1.0 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 0.3 | 0.7 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
| 0.3 | 2.0 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 0.3 | 0.6 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
| 0.3 | 10.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.3 | 2.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.3 | 3.1 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.3 | 4.1 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 0.3 | 1.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.3 | 2.4 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.3 | 6.3 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.3 | 1.2 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) |
| 0.3 | 0.9 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
| 0.3 | 4.7 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.3 | 2.4 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
| 0.3 | 8.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.3 | 0.9 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.3 | 2.6 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.3 | 2.0 | GO:0000989 | transcription factor activity, transcription factor binding(GO:0000989) |
| 0.3 | 1.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 0.3 | 2.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.3 | 1.1 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 0.3 | 2.5 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
| 0.3 | 0.8 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
| 0.3 | 0.8 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.3 | 17.2 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.3 | 2.2 | GO:0042826 | histone deacetylase binding(GO:0042826) |
| 0.3 | 1.6 | GO:0097001 | ceramide binding(GO:0097001) |
| 0.3 | 4.4 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.3 | 1.6 | GO:0044594 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
| 0.3 | 3.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.3 | 1.1 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
| 0.3 | 1.1 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.3 | 0.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.3 | 3.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
| 0.3 | 1.0 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
| 0.3 | 1.0 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.2 | 1.7 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.2 | 3.2 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 0.2 | 5.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.2 | 1.4 | GO:0052843 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 0.2 | 1.6 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.2 | 0.2 | GO:0047017 | prostaglandin-F synthase activity(GO:0047017) |
| 0.2 | 0.7 | GO:0033149 | FFAT motif binding(GO:0033149) |
| 0.2 | 5.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.2 | 1.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 0.2 | 1.4 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 0.2 | 1.1 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.2 | 1.8 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.2 | 1.6 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.2 | 0.9 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.2 | 2.9 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
| 0.2 | 2.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.2 | 2.0 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 0.2 | 12.7 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.2 | 2.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.2 | 1.1 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 0.2 | 1.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.2 | 0.6 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.2 | 0.6 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 0.2 | 0.4 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.2 | 0.4 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 0.2 | 0.8 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.2 | 1.0 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.2 | 0.8 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.2 | 3.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.2 | 2.6 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.2 | 0.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 0.2 | 1.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 0.2 | 0.8 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.2 | 2.7 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.2 | 0.9 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 0.2 | 0.9 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 0.2 | 2.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.2 | 2.2 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.2 | 2.0 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.2 | 6.4 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.2 | 2.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.2 | 1.6 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.2 | 1.8 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
| 0.2 | 0.4 | GO:0071253 | connexin binding(GO:0071253) |
| 0.2 | 5.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.2 | 1.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.2 | 10.5 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.2 | 21.1 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.2 | 3.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.2 | 2.2 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
| 0.2 | 1.5 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.2 | 1.3 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.2 | 0.6 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.2 | 2.7 | GO:0032052 | bile acid binding(GO:0032052) |
| 0.2 | 4.0 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.2 | 1.3 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
| 0.2 | 0.5 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
| 0.2 | 0.6 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.2 | 4.0 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.2 | 0.5 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
| 0.2 | 2.9 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 0.2 | 1.5 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.2 | 3.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.2 | 0.6 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.1 | 0.9 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.1 | 1.3 | GO:0043426 | MRF binding(GO:0043426) |
| 0.1 | 0.6 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
| 0.1 | 2.9 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.1 | 0.4 | GO:0050577 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
| 0.1 | 1.7 | GO:0030546 | receptor activator activity(GO:0030546) |
| 0.1 | 2.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.1 | 1.1 | GO:0030172 | troponin C binding(GO:0030172) |
| 0.1 | 0.7 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.1 | 1.6 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.1 | 4.9 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.1 | 2.6 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.1 | 2.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.1 | 0.4 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.1 | 1.7 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.1 | 1.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.1 | 2.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.1 | 0.8 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.1 | 3.4 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.1 | 2.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
| 0.1 | 3.2 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.1 | 5.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.1 | 1.7 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.1 | 11.7 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
| 0.1 | 6.7 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
| 0.1 | 0.4 | GO:0086039 | lutropin-choriogonadotropic hormone receptor binding(GO:0031775) calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential(GO:0086039) |
| 0.1 | 1.9 | GO:0017022 | myosin binding(GO:0017022) |
| 0.1 | 2.7 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.1 | 1.6 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
| 0.1 | 6.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.1 | 0.5 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.1 | 1.3 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.1 | 2.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.1 | 8.0 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.1 | 2.7 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.1 | 0.8 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.1 | 0.6 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
| 0.1 | 0.7 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
| 0.1 | 0.9 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.1 | 0.8 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.1 | 3.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.1 | 2.5 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.1 | 3.3 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.1 | 1.9 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.1 | 0.1 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
| 0.1 | 1.7 | GO:0015924 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
| 0.1 | 0.3 | GO:0016768 | spermine synthase activity(GO:0016768) |
| 0.1 | 36.1 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
| 0.1 | 3.9 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.1 | 1.7 | GO:0016874 | ligase activity(GO:0016874) |
| 0.1 | 0.6 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
| 0.1 | 5.5 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
| 0.1 | 1.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.1 | 3.7 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.1 | 0.2 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
| 0.1 | 1.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.1 | 1.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.1 | 0.5 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.1 | 1.1 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 0.1 | 3.2 | GO:0035326 | enhancer binding(GO:0035326) |
| 0.1 | 0.8 | GO:0098639 | C-X3-C chemokine binding(GO:0019960) collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.1 | 2.7 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
| 0.1 | 1.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
| 0.1 | 0.7 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.1 | 11.7 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
| 0.1 | 3.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.1 | 0.7 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
| 0.1 | 0.2 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
| 0.1 | 3.7 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.1 | 0.6 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.1 | 2.4 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.1 | 1.4 | GO:0045295 | gamma-catenin binding(GO:0045295) |
| 0.1 | 1.4 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.1 | 0.4 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
| 0.1 | 9.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.1 | 10.7 | GO:0005518 | collagen binding(GO:0005518) |
| 0.1 | 0.4 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.1 | 2.8 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.1 | 0.8 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.1 | 0.3 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
| 0.1 | 6.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.1 | 3.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.1 | 0.6 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.1 | 0.3 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
| 0.1 | 2.1 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.1 | 3.9 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.1 | 1.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.1 | 0.2 | GO:0090541 | MIT domain binding(GO:0090541) |
| 0.1 | 0.3 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
| 0.1 | 0.7 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) SUMO binding(GO:0032183) |
| 0.1 | 1.6 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.1 | 6.3 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.1 | 1.0 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.1 | 0.5 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.1 | 1.1 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
| 0.1 | 1.8 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.1 | 0.7 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.1 | 0.7 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.1 | 0.3 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 0.1 | 0.5 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.1 | 0.4 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.1 | 2.1 | GO:0008483 | transaminase activity(GO:0008483) |
| 0.1 | 2.9 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.1 | 0.6 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.1 | 0.5 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 0.1 | 0.7 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.1 | 1.4 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.1 | 3.9 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.1 | 0.7 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.1 | 0.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.1 | 1.8 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.1 | 0.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.1 | 3.7 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.1 | 1.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.1 | 1.5 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.1 | 3.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
| 0.1 | 2.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.1 | 3.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.1 | 0.3 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
| 0.1 | 10.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.1 | 0.5 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 0.1 | 0.8 | GO:0036122 | BMP binding(GO:0036122) |
| 0.1 | 1.0 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 0.1 | 1.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.1 | 0.3 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
| 0.1 | 1.7 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 0.1 | 0.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.1 | 0.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.1 | 1.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.1 | 8.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.1 | 12.3 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.1 | 0.5 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.1 | 1.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.1 | 0.1 | GO:0070883 | pre-miRNA binding(GO:0070883) pre-miRNA transporter activity(GO:0090631) |
| 0.1 | 0.2 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
| 0.1 | 4.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.1 | 0.4 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.1 | 2.1 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.1 | 1.2 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 0.1 | 0.6 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.1 | 0.8 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.1 | 0.2 | GO:0061599 | molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
| 0.1 | 0.9 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.1 | 26.2 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.1 | 1.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.1 | 3.7 | GO:0001047 | core promoter binding(GO:0001047) |
| 0.1 | 0.7 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
| 0.1 | 4.1 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
| 0.1 | 1.1 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
| 0.1 | 0.5 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.1 | 0.2 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.1 | 3.3 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
| 0.1 | 10.8 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.1 | 4.5 | GO:0008013 | beta-catenin binding(GO:0008013) |
| 0.1 | 1.0 | GO:0004659 | prenyltransferase activity(GO:0004659) |
| 0.1 | 0.6 | GO:0004630 | phospholipase D activity(GO:0004630) |
| 0.0 | 0.7 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
| 0.0 | 1.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.0 | 2.4 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
| 0.0 | 0.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.0 | 0.4 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.0 | 0.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.0 | 0.4 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.0 | 2.7 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.0 | 1.3 | GO:0043028 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
| 0.0 | 0.9 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.0 | 1.9 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
| 0.0 | 0.2 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 0.0 | 0.4 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
| 0.0 | 0.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.0 | 0.3 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.0 | 0.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.0 | 0.3 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
| 0.0 | 0.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.0 | 0.1 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 0.0 | 0.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.0 | 4.3 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.0 | 0.5 | GO:0019213 | deacetylase activity(GO:0019213) |
| 0.0 | 2.4 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.0 | 0.3 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
| 0.0 | 1.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.0 | 4.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
| 0.0 | 1.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.0 | 0.2 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 0.0 | 0.2 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
| 0.0 | 0.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.0 | 0.1 | GO:0048040 | UDP-glucuronate decarboxylase activity(GO:0048040) |
| 0.0 | 0.2 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.0 | 1.0 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.0 | 1.7 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 0.0 | 0.6 | GO:0001221 | transcription cofactor binding(GO:0001221) |
| 0.0 | 0.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.0 | 4.2 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
| 0.0 | 0.2 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
| 0.0 | 0.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
| 0.0 | 0.5 | GO:0043621 | protein self-association(GO:0043621) |
| 0.0 | 0.2 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
| 0.0 | 1.8 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.0 | 0.1 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.0 | 0.4 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
| 0.0 | 0.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
| 0.0 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.0 | 0.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.0 | 0.3 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.0 | 0.2 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.0 | 0.7 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.0 | 0.3 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.0 | 0.6 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) TFIIB-class transcription factor binding(GO:0001093) |
| 0.0 | 0.1 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.0 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 0.0 | 0.1 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
| 0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 0.0 | 0.8 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.0 | 0.1 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.0 | 0.2 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.0 | 0.2 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
| 0.0 | 0.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.0 | 0.6 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.0 | 0.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 0.0 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.0 | 0.5 | GO:0042166 | acetylcholine binding(GO:0042166) |
| 0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 0.0 | 1.4 | GO:0043130 | ubiquitin binding(GO:0043130) |
| 0.0 | 0.3 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
| 0.0 | 0.6 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.0 | 0.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.0 | 0.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.0 | 0.7 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 0.0 | 0.2 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
| 0.0 | 0.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.0 | 0.1 | GO:0061714 | folic acid receptor activity(GO:0061714) |
| 0.0 | 0.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
| 0.0 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 0.0 | 0.1 | GO:0042165 | neurotransmitter binding(GO:0042165) |
| 0.0 | 0.3 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
| 0.0 | 0.2 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.0 | 0.9 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.0 | 0.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.0 | 0.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.0 | 0.2 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
| 0.0 | 0.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.0 | 0.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.0 | 0.9 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.0 | 0.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.0 | 0.3 | GO:0070851 | growth factor receptor binding(GO:0070851) |
| 0.0 | 0.2 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.0 | 0.4 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
| 0.0 | 0.4 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.0 | 0.4 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
| 0.0 | 0.4 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.0 | 1.1 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
| 0.0 | 0.0 | GO:0004818 | glutamate-tRNA ligase activity(GO:0004818) |
| 0.0 | 0.3 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.0 | 0.1 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
| 0.0 | 0.6 | GO:0032934 | sterol binding(GO:0032934) |
| 0.0 | 0.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.0 | 0.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.0 | 0.2 | GO:0043236 | laminin binding(GO:0043236) |
| 0.0 | 5.7 | GO:0005525 | GTP binding(GO:0005525) |
| 0.0 | 0.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.0 | 1.1 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.0 | 0.1 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
| 0.0 | 0.8 | GO:0030674 | protein binding, bridging(GO:0030674) |
| 0.0 | 0.3 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.0 | 0.4 | GO:0043022 | ribosome binding(GO:0043022) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.6 | 15.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.5 | 1.8 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.3 | 2.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.3 | 22.7 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.3 | 2.1 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.3 | 1.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.3 | 10.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.3 | 1.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.3 | 20.8 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.3 | 2.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
| 0.2 | 10.4 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
| 0.2 | 1.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.2 | 8.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.2 | 11.6 | PID MYC PATHWAY | C-MYC pathway |
| 0.2 | 25.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.2 | 4.4 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.2 | 1.5 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.2 | 15.7 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.2 | 14.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.2 | 7.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.2 | 1.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.2 | 9.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.2 | 7.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.2 | 8.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.2 | 10.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.2 | 2.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.2 | 12.1 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.2 | 0.7 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.2 | 7.5 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.2 | 2.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.2 | 3.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.2 | 1.4 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.2 | 5.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.2 | 7.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.1 | 3.6 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.1 | 0.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.1 | 6.9 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.1 | 3.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.1 | 13.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.1 | 1.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.1 | 3.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.1 | 1.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.1 | 4.8 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.1 | 2.1 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.1 | 1.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.1 | 2.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.1 | 6.7 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.1 | 10.8 | PID P73PATHWAY | p73 transcription factor network |
| 0.1 | 3.9 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.1 | 0.8 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.1 | 2.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.1 | 4.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.1 | 1.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.1 | 4.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.1 | 2.3 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.1 | 8.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.1 | 3.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.1 | 4.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.1 | 4.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.1 | 3.0 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.1 | 1.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.1 | 4.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.1 | 2.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.1 | 2.7 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.1 | 1.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.1 | 1.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.1 | 1.8 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.1 | 4.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.1 | 1.0 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.1 | 0.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.0 | 1.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.0 | 3.0 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.0 | 0.7 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.0 | 1.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.0 | 0.1 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.0 | 0.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.0 | 0.8 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.0 | 1.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.0 | 0.6 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.0 | 0.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.0 | 1.4 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.0 | 5.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.0 | 0.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.0 | 1.4 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.0 | 0.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.0 | 0.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.0 | 0.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.0 | 22.9 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.5 | 10.0 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.5 | 14.0 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
| 0.4 | 9.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.4 | 0.9 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.4 | 3.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.4 | 11.7 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
| 0.3 | 7.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.3 | 3.8 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.3 | 6.0 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.3 | 12.2 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.3 | 9.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.2 | 4.4 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 0.2 | 2.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.2 | 18.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.2 | 7.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.2 | 8.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.2 | 0.9 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.2 | 4.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.2 | 11.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.2 | 5.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.2 | 6.6 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.2 | 10.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.2 | 4.1 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.2 | 19.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.2 | 0.6 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.2 | 2.8 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.2 | 5.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.2 | 6.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.2 | 4.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.2 | 9.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.2 | 1.0 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.2 | 0.7 | REACTOME PI3K EVENTS IN ERBB2 SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
| 0.2 | 4.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.2 | 1.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.2 | 0.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 0.2 | 10.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.1 | 5.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.1 | 6.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.1 | 2.3 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.1 | 6.0 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.1 | 2.9 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.1 | 6.8 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.1 | 3.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.1 | 3.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.1 | 8.0 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.1 | 1.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.1 | 13.6 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.1 | 8.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.1 | 4.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.1 | 1.4 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 0.1 | 5.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.1 | 1.9 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.1 | 6.0 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.1 | 1.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.1 | 2.7 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 0.1 | 7.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.1 | 2.6 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.1 | 2.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.1 | 1.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.1 | 3.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.1 | 1.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.1 | 2.7 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.1 | 1.9 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.1 | 2.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 0.1 | 2.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.1 | 3.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.1 | 0.8 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.1 | 1.2 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
| 0.1 | 0.7 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
| 0.1 | 6.6 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.1 | 5.4 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.1 | 1.0 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.1 | 1.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.1 | 1.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.1 | 2.6 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.1 | 2.1 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.1 | 1.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.1 | 2.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.1 | 1.1 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.1 | 2.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.1 | 0.7 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 0.1 | 1.1 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.1 | 2.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.1 | 1.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.1 | 0.8 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.1 | 5.7 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.1 | 2.7 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.1 | 3.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.1 | 1.7 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
| 0.1 | 1.9 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.1 | 3.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.1 | 1.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.1 | 1.8 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
| 0.1 | 5.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.1 | 1.4 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
| 0.1 | 1.6 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
| 0.1 | 0.4 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
| 0.1 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.1 | 1.6 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
| 0.1 | 1.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.0 | 0.8 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 0.0 | 0.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.0 | 1.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.0 | 4.5 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
| 0.0 | 2.2 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.0 | 1.1 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.0 | 1.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.0 | 0.9 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.0 | 1.0 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.0 | 1.6 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.0 | 0.9 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
| 0.0 | 0.9 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
| 0.0 | 0.5 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
| 0.0 | 0.8 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.0 | 0.4 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.0 | 0.5 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.0 | 1.8 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.0 | 0.6 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
| 0.0 | 3.7 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 0.0 | 5.2 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.0 | 0.1 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
| 0.0 | 0.9 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.0 | 0.4 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
| 0.0 | 0.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.0 | 1.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.0 | 0.9 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.0 | 0.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.0 | 1.1 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
| 0.0 | 1.9 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.0 | 1.7 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.0 | 0.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.0 | 0.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.0 | 0.1 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
| 0.0 | 0.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.0 | 0.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.0 | 0.6 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.0 | 0.1 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
| 0.0 | 0.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.0 | 0.1 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
| 0.0 | 0.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |